KeifeRX Announces Research Collaboration & Option Agreement With Amneal Pharmaceuticals
Jan 9 (Reuters) - KeifeRX:
KEIFERX ANNOUNCES RESEARCH COLLABORATION AND OPTION AGREEMENT WITH AMNEAL PHARMACEUTICALS TO ADVANCE KFRX06, A BRAIN-PENETRANT LRRK2 PROGRAM FOR PARKINSON’S DISEASE
KEIFERX: FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.